Highlights in COVID-19 From the 62nd American Society of Hematology Annual Meeting

Highlights in COVID-19 From the 62nd American Society of Hematology Annual Meeting December 5-8, 2020, Virtual The high incidence of venous thromboembolism (VTE) and its consequent […]

CLL In Focus

CLL Linked to Elevated Risk for Second Cancers Even With BTK Inhibition Patients with chronic lymphocytic leukemia (CLL) are at increased risk for second cancers even […]

Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic

H&O What are the goals of the CAR T-Cell Consortium? MB The initial aim of the CAR T-Cell Consortium was to evaluate real-world experience with […]

COVID-19 and Hypercoagulability

H&O What are the manifestations of COVID-19 that relate to coagulation? MS The manifestations of coronavirus disease 2019 (COVID-19) that relate to coagulation appear to […]

Providing Oncology Care During the COVID-19 Pandemic

H&O What has it been like practicing oncology in Washington state over the past few months? GL Most of my insights are based on the […]

COVID-19 in HEM/ONC News

Tocilizumab May Help Patients With COVID-19 and Myeloma The immunosuppressant tocilizumab (Actemra, Genentech) may be an effective treatment for severe coronavirus disease 2019 (COVID-19) in patients […]